INCYTE CORP (INCY)
Data as of , from SEC Form 4 filings.
See up to 3 months of INCY. The 7-day demo opens the 1M and 3M ranges and puts INCY on your watchlist.
Start 7-day demoLatest INCY insider trades
Pablo J. Cagnoni - OfficerOpen-market sale$1.11M- Pablo J. Cagnoni - OfficerOpen-market sale$1.69M
About INCYTE CORP (INCY)
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
- WILMINGTON, DE
- 2,844
- 1993
- XNAS
INCY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 21 | 124,481 | $15.01M |
| Grant or award | 34 | 680,342 | |
| Option exercise | 42 | 142,384 | |
INCY insider transactions (Form 4)
68139 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Pablo J. Cagnoni - Officer | Option exercise | Common Stock | 7,166 | $61.18 | $438K | |
| Pablo J. Cagnoni - Officer | Option exercise | Common Stock | 11,501 | $64.25 | $739K | |
| Pablo J. Cagnoni - Officer | Open-market sale | Common Stock | 18,667 | $94.24 | $1.76M | |
| Pablo J. Cagnoni - Officer | Option exercise | Employee Stock Option (right to buy) | 7,166 | $0.00 | - | |
| Pablo J. Cagnoni - Officer | Option exercise | Employee Stock Option (right to buy) | 11,501 | $0.00 | - | |
| Pablo J. Cagnoni - Officer | Option exercise | Common Stock | 13,093 | $61.76 | $809K | |
| Pablo J. Cagnoni - Officer | Option exercise | Common Stock | 5,575 | $61.18 | $341K | |
| Pablo J. Cagnoni - Officer | Open-market sale | Common Stock | 18,668 | $100.91 | $1.88M | |
| Pablo J. Cagnoni - Officer | Option exercise | Employee Stock Option (right to buy) | 13,093 | $0.00 | - | |
| Pablo J. Cagnoni - Officer | Option exercise | Employee Stock Option (right to buy) | 5,575 | $0.00 | - | |
| Michael James Morrissey - Officer | Tax withholding / forfeiture | Common Stock | 185 footnote F1 | $102.67 | $19K | |
| ||||||
| Lee Heeson - Officer | Tax withholding / forfeiture | Common Stock | 111 footnote F1 | $102.67 | $11K | |
| ||||||
| Lee Heeson - Officer | Grant or award | Common Stock | 8,911 footnote F1 | $0.00 | - | |
| ||||||
| Pablo J. Cagnoni - Officer | Grant or award | Employee Stock Option (right to buy) | 28,475 | $0.00 | - | |
| Steven H. Stein - Officer | Grant or award | Employee Stock Option (right to buy) | 19,932 | $0.00 | - | |
| Mohamed Khairie Issa - Officer | Grant or award | Employee Stock Option (right to buy) | 14,237 | $0.00 | - | |
| Matteo Trotta - Officer | Grant or award | Employee Stock Option (right to buy) | 8,542 | $0.00 | - | |
| Michael James Morrissey - Officer | Grant or award | Common Stock | 7,426 footnote F1 | $0.00 | - | |
| Michael James Morrissey - Officer | Tax withholding / forfeiture | Common Stock | 429 footnote F2 | $102.62 | $44K | |
| ||||||
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 328 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 328 | $0.00 | - | |
| Richard A. Hoffman - Officer | Grant or award | Common Stock | 9,466 footnote F1 | $0.00 | - | |
| Richard A. Hoffman - Officer | Grant or award | Employee Stock Option (right to buy) | 43,301 | $0.00 | - | |
| Richard A. Hoffman - Officer | Grant or award | Performance Shares | 23,665 | $0.00 | - | |
| ||||||
| Michael James Morrissey - Officer | Tax withholding / forfeiture | Common Stock | 326 footnote F1 | $102.04 | $33K | |
| ||||||
| Steven H. Stein - Officer | Open-market sale | Common Stock | 2,559 | $102.96 | $263K | |
| Steven H. Stein - Officer | Tax withholding / forfeiture | Common Stock | 17,093 footnote F1 | $102.04 | $1.74M | |
| Steven H. Stein - Officer | Open-market sale | Common Stock | 20,105 | $102.51 | $2.06M | |
| ||||||
| Thomas Tray - Officer | Open-market sale | Common Stock | 169 | $102.00 | $17K | |
| Thomas Tray - Officer | Open-market sale | Common Stock | 600 | $103.00 | $62K | |
 Sheila A. Denton - Officer | Open-market sale | Common Stock | 278 | $104.36 | $29K | |
| Sheila A. Denton - Officer | Option exercise | Employee Stock Option (right to buy) | 278 | $0.00 | - | |
| Sheila A. Denton - Officer | Option exercise | Common Stock | 278 | $64.25 | $18K | |
| Herve Hoppenot - Director | Open-market sale | Common Stock | 187,500 | $105.46 | $19.77M | |
| Steven H. Stein - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 2,995 | $0.00 | - | |
| Steven H. Stein - Officer | Option exercise | Incentive Stock Option (right to buy) | 1,044 | $0.00 | - | |
| Steven H. Stein - Officer | Option exercise | Common Stock | 1,194 | $83.83 | $100K | |
| Steven H. Stein - Officer | Option exercise | Common Stock | 2,995 | $95.76 | $287K | |
| Steven H. Stein - Officer | Option exercise | Common Stock | 1,044 | $95.76 | $100K | |
| Steven H. Stein - Officer | Open-market sale | Common Stock | 5,233 | $102.20 | $535K | |
| Steven H. Stein - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 1,194 | $0.00 | - | |
| Sheila A. Denton - Officer | Option exercise | Common Stock | 598 | $58.06 | $35K | |
| Sheila A. Denton - Officer | Open-market sale | Common Stock | 598 | $101.36 | $61K | |
| Sheila A. Denton - Officer | Option exercise | Employee Stock Option (right to buy) | 598 | $0.00 | - | |
| Lee Heeson - Officer | Open-market sale | Common Stock | 3,074 | $94.02 | $289K | |
| Sheila A. Denton - Officer | Option exercise | Common Stock | 277 | $64.25 | $18K | |
| Sheila A. Denton - Officer | Open-market sale | Common Stock | 277 | $85.13 | $24K | |
| Sheila A. Denton - Officer | Option exercise | Employee Stock Option (right to buy) | 277 | $0.00 | - | |
| Sheila A. Denton - Officer | Option exercise | Common Stock | 599 | $58.06 | $35K | |
| Sheila A. Denton - Officer | Open-market sale | Common Stock | 599 | $87.65 | $53K | |
| Sheila A. Denton - Officer | Tax withholding / forfeiture | Common Stock | 3,130 footnote F1 | $86.28 | $270K | |
| Sheila A. Denton - Officer | Open-market sale | Common Stock | 3,501 | $85.54 | $299K | |
| Sheila A. Denton - Officer | Option exercise | Employee Stock Option (right to buy) | 599 | $0.00 | - | |
| ||||||
 Patrick A. Mayes - Officer | Tax withholding / forfeiture | Common Stock | 1,569 footnote F1 | $86.70 | $136K | |
| ||||||
| Lee Heeson - Officer | Tax withholding / forfeiture | Common Stock | 463 footnote F1 | $86.70 | $40K | |
| ||||||
| Paul J. Clancy - Director | Grant or award | Common Stock | 285 | $84.81 | $24K | |
| Edmund Harrigan - Director | Grant or award | Common Stock | 289 | $84.81 | $25K | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 388 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 388 | $0.00 | - | |
| David H. Gardner - Officer | Grant or award | Common Stock | 9,429 | $0.00 | - | |
| David H. Gardner - Officer | Grant or award | Performance Shares | 23,573 | $0.00 | - | |
| David H. Gardner - Officer | Grant or award | Employee Stock Option (right to buy) | 42,899 | $0.00 | - | |
| Sheila A. Denton - Officer | Option exercise | Common Stock | 278 | $64.25 | $18K | |
| Sheila A. Denton - Officer | Open-market sale | Common Stock | 278 | $83.15 | $23K | |
| Sheila A. Denton - Officer | Option exercise | Employee Stock Option (right to buy) | 278 | $0.00 | - | |
| Sheila A. Denton - Officer | Option exercise | Common Stock | 598 | $58.06 | $35K | |
| Sheila A. Denton - Officer | Open-market sale | Common Stock | 598 | $84.97 | $51K | |
| Sheila A. Denton - Officer | Option exercise | Employee Stock Option (right to buy) | 598 | $0.00 | - | |
See every INCY filing on record
These pages show the latest 90 of 139 Form 4 filings on record. The 7-day demo shows all 139, and sign-up brings you back to this table.
Item 8.01
Item 2.02, 9.01
Item 8.01, 9.01
Item 8.01
Recent INCY Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| PABLO CAGNONI | Officer | 23,218 | $2.80M | View on EDGAR | |
| PABLO CAGNONI | Officer | 10,801 | $1.36M |
INCY insider trading FAQ
What is the latest insider trade for INCY?
INCYTE CORP (INCY) had 24 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for INCY runs to 139 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INCY stock?
No insider purchases of INCY were filed in the last 90 days.
How many insiders are selling INCY stock?
21 insider sales of INCY were filed in the last 90 days, totaling $15.01M.
Where can I see INCY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INCY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Lee Heeson view on EDGAR
- - BAKER BROS. ADVISORS LP view on EDGAR
- - Paul J. Clancy view on EDGAR
- - Edmund Harrigan view on EDGAR
- - David H. Gardner view on EDGAR
- - Pablo J. Cagnoni view on EDGAR
- - Ramitpal K. Basi view on EDGAR
- - Pablo J. Cagnoni view on EDGAR
- - Pablo J. Cagnoni view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where INCY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INCY with a 7-day demo
- INCY on your watchlist
- Every INCY Form 4 filing on record
- Up to 3 months of INCY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
